Abstract:Du Meng, 1,* Hongwei Lei, 2,* Xiaoqiang Zheng, 3 Yaxuan Han, 4 Ronggang Sun, 5 Dongli Zhao, 1 Rui Liu 1 1 Department of Radio Oncology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi Province, 710061, People's Republic of China; 2 Department of Radio Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, 116027, People's Republic of China; 3 Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an, Shaanxi Province, 710061, People's Republic of China; 4 Department of Oncology, The Xi'an Chest Hospital, Xi'an, Shaanxi Province, 710000, People's Republic of China; 5 Department of Radio Oncology, The People's Hospital of YangZhong City, YangZhong, Jiangsu Province, 212200, People's Republic of China *These authors contributed equally to this work Background: Breast cancer is one of the foremost threats to female health nowadays. Tamoxifen, an antagonist of estrogen receptor-α (ERα), is the first choice for endocrine-dependent breast cancer (ERα-positive breast cancer) treatment. However, ERα has an important function in the normal physical regulation of estrogen, and current oral administration of tamoxifen has potential side effects on normal endocrine secretion. In the present work, we aim to develop novel approaches to increase the antitumor effect of tamoxifen on breast cancer cells and decrease the potential side effects in the human body during treatment. Methods: A temperature-sensitive phase-change hydrogel for tamoxifen (Tam-Gel) was generated. After establishing subcutaneous tumors formed by MCF-7, an ERα-positive breast cancer cell line, in nude mice, an intratumoral injection of Tam-Gel was performed to examine whether Tam-Gel facilitated the slow-release or antitumor effect of tamoxifen. A metastatic breast cancer model was established using the intrahepatic growth of MCF-7 cells in immunodeficient rats. Results: Tam-Gel can transform from liquid to hydrogel at room temperature. An intratumoral injection of Tam-Gel facilitated the slow-release or antitumor effect of tamoxifen. Once Tam-Gel, but not Tam-Sol, was administered by intratumoral injection, it significantly decreased the uptake of radionuclide probes ( 18 F-fluoroestradiol or 18 F-fluorodeoxyglucose) by cells in rats' livers and the intrahepatic growth of MCF-7 cells in rats' livers. Conclusion: A novel slow-release system was successfully prepared to facilitate the long-term release of tamoxifen in breast cancer tissues, and achieved an antitumor effect in the long term. Keywords: breast cancer, estrogen receptor-α, tamoxifen nanoparticle, temperature-sensitive phase-change hydrogel

In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice

Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging

Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapy

Alterations of Genetic Variants and Transcriptomic Features of Response to Tamoxifen in the Breast Cancer Cell Line

Identification of differentially expressed genes in human breast cancer cells induced by 4-hydroxyltamoxifen and elucidation of their pathophysiological relevance and mechanisms

Tamoxifen induces radioresistance through NRF2-mediated metabolic reprogramming in breast cancer

Molecular Imaging of Tumor-Infiltrating Macrophages in a Preclinical Mouse Model of Breast Cancer.

[Experimental chemo- and chemoendocrine therapy of human breast carcinomas serially transplanted into nude mice]

[Effect of Mitogen-Activated Protein Kinase Signal Transduction in Non-Estrogen Antagonistic Mechanism of Tamoxifen].

Non-invasive monitoring of the growth of breast cancer cells in bone environment using the optical imaging system

Nanosecond Pulsed Electric Fields Caused Breast Cancer Self-Distruction: under in Vivo Magnetic Resonance Imaging Evaluation

A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells

Persistent Metabolic Effects of Tamoxifen: Considerations for an Experimental Tool and Clinical Breast Cancer Treatment

Evaluation of metronomic chemotherapy response using diffusion and dynamic contrast-enhanced MRI

Tamoxifen administration induces histopathologic changes within the lungs of Cre-recombinase-negative mice: A case report

Therapeutic effect of positron emission tomography agent 18F-FDG on MCF-7 in nude mice

Experimental Study on Inhibition of Bioactivity of Tamoxifen-Resistant Breast Cancer Cells by Emodin

Studies on Resistant Induction of Breast Cancer Cell MCF-7 to Tamoxifen in Vitro

Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice

Tamoxifen promotes apoptosis and inhibits invasion in estrogen‑positive breast cancer MCF‑7 cells.

Ultrasonic RF Time Series for Early Assessment of Tumor Response to Chemotherapy: First in Vivo Studies on Mice Breast Cancer Model